# Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism

> **NCT01004939** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 120 (actual)

## Conditions studied

- Thromboembolism
- Venous Thromboembolism

## Interventions

- **DRUG:** fondaparinux

## Key facts

- **NCT ID:** NCT01004939
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2011-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004939, "Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT01004939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*